Emre, S. Et Al. 2024. Antipsychotic-Treated Schizophrenia Patients Develop Inflammatory and Oxidative Responses Independently From Obesity: However, Metabolic Disturbances Arise From Schizophrenia-Related Obesity. Human Psychopharmacology , vol.39, no.6 .

Emre, S., Asli, S., Sener, M., EKER, S. S., & Esma, S., (2024). Antipsychotic-Treated Schizophrenia Patients Develop Inflammatory and Oxidative Responses Independently From Obesity: However, Metabolic Disturbances Arise From Schizophrenia-Related Obesity. Human Psychopharmacology , vol.39, no.6.

Emre, Sarandol Et Al. "Antipsychotic-Treated Schizophrenia Patients Develop Inflammatory and Oxidative Responses Independently From Obesity: However, Metabolic Disturbances Arise From Schizophrenia-Related Obesity," Human Psychopharmacology , vol.39, no.6, 2024

Emre, Sarandol Et Al. "Antipsychotic-Treated Schizophrenia Patients Develop Inflammatory and Oxidative Responses Independently From Obesity: However, Metabolic Disturbances Arise From Schizophrenia-Related Obesity." Human Psychopharmacology , vol.39, no.6, 2024

Emre, S. Et Al. (2024) . "Antipsychotic-Treated Schizophrenia Patients Develop Inflammatory and Oxidative Responses Independently From Obesity: However, Metabolic Disturbances Arise From Schizophrenia-Related Obesity." Human Psychopharmacology , vol.39, no.6.

@article{article, author={Sarandol Emre Et Al. }, title={Antipsychotic-Treated Schizophrenia Patients Develop Inflammatory and Oxidative Responses Independently From Obesity: However, Metabolic Disturbances Arise From Schizophrenia-Related Obesity}, journal={Human Psychopharmacology}, year=2024}